US4557863A - Device for collection of proteins in a urinal and method of use - Google Patents
Device for collection of proteins in a urinal and method of use Download PDFInfo
- Publication number
- US4557863A US4557863A US06/600,081 US60008184A US4557863A US 4557863 A US4557863 A US 4557863A US 60008184 A US60008184 A US 60008184A US 4557863 A US4557863 A US 4557863A
- Authority
- US
- United States
- Prior art keywords
- layer
- adsorbent
- urine
- conduit
- proteins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
- A61B10/0045—Devices for taking samples of body liquids
- A61B10/007—Devices for taking samples of body liquids for taking urine samples
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L28/00—Materials for colostomy devices
- A61L28/0034—Use of materials characterised by their function or physical properties
- A61L28/0038—Medicaments; Biocides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/814—Enzyme separation or purification
- Y10S435/815—Enzyme separation or purification by sorption
Definitions
- the invention relates to apparatus means useful when installed in a urinal for collection of urinary proteins. More particularly, the invention relates to a device and method of use comprising conduit means for gravity feed passage of urine streams therethrough and permeable layers in the conduit containing an antimicrobial agent and an adsorbent for collection of urinary proteins as an adsorbate such that the anti-microbial provides for effective inhibition of both microbial growth and consequent degradation of wanted proteins in the collected adsorbate during the period of collection.
- Mammalian urine contains small percentages of a variety of proteins and especially enzymes which have commercial value, usually as pharmaceuticals.
- the enzyme urokinase which is a plasminogen activator and is present in trace percentages in human urine, is widely used as a fibrinolytic agent in humans and in connection with treatment for cancer because of its ability to cause dissolution of the fibrin growths which sometimes sheath tumors.
- Most of the commercial supply of urokinase is now derived from urine by the collection of urine from paid donors who regularly visit central collection stations. Within a few hours of being collected the urine is transported to a central processing station where it is intermixed with adsorbents that attract the large protein molecules of interest.
- U.S. Pat. No. 3,755,083 discloses a process of this type. It is also known to collect urokinase on an adsorbent placed in a urinal as illustrated by U.S. Pat. No. 3,711,377. Exemplary known adsorbents for urokinase include bentonite (U.S. Pat. No. 3,555,361), and Florosil, charcoal, and aluminum oxide. Other urinary substances of importance are peptide hormones such as human growth hormone (The Merck Index, monograph 7290, 9th Ed.), glycoproteins such as erythropoetin (Merck 3610), and the like.
- Urinary proteins rapidly degenerate at normal collection temperatures so that it is necessary to process the urine either during collection or as soon as possible thereafter.
- the resulting collection and processing costs and the low percentage of wanted proteins such as urokinase contained in urine result in a very high unit cost, severely limiting pharmaceutical use of the materials.
- the present invention is directed to a novel device for the collection of urinary proteins comprising a columnar conduit or cartridge containing in series an anitbacterial component and adsorbent for proteins.
- the device is useful when installed in a urinal for collection of urinary proteins, especially human urinary proteins, as an adsorbate, for later isolation and purification of its content of valuable urinary proteins having application, e.g., as pharmaceutically active agents in human or veterinary medicine.
- the adsorbent means more particularly comprises a columnar conduit adapted for gravity feed passage of urine streams therethrough, and first and second urine-stream permeable layers in the conduit, the first and second layers comprising respectively a leachable antimicrobial agent and a suitable adsorbent for urinary proteins.
- the columnar conduit for purposes of the invention, can be any suitable open-ended container such as a pipe or plastic tube, sieve, or container removably placed in a urinal, allowing gravity flow therethrough of urine streams but so placed that water for flushing, if any, is by-passed, that is to say, the flow through the conduit does not include water flow.
- a suitable open-ended container such as a pipe or plastic tube, sieve, or container removably placed in a urinal, allowing gravity flow therethrough of urine streams but so placed that water for flushing, if any, is by-passed, that is to say, the flow through the conduit does not include water flow.
- the first permeable layer in the conduit contains a leachable water soluble hydrophilic component comprising (1) a water soluble antimicrobial that is leached ratably by exposure to intermittent urine streams and (2) a water-insoluble hydrophobic component that sublimes ratably to the air, the respective rates of leaching and subliming during the service life being chosen such that the leaching of antimicrobial from the first layer into the second layer is sufficient to provide an inhibitor concentration effectively inhibiting microbial degradation of wanted proteins contained in the adsorbate of the second layer.
- the hydrophilic component of the first layer comprises a water-soluble antimicrobial agent (sometimes referred to herein as an antibacterial).
- the antimicrobial agent is an antimicrobial substance or mixture of antimicrobial substances that is compatible with the adsorbent and the urinary proteins and that serves to inhibit the degradation of urinary proteins in the adsorbate of the second layer as by elimination of bacterial growth and hence bacterial degradation of urinary proteins such as urokinase and the like.
- a preferred antimicrobial agent for purposes of the invention, is one that inhibits microbial degradation of urokinase.
- one may use any suitable water-soluble antibacterial substance that is effective in preventing or inhibiting degradation of the desired urinary proteins.
- Preferred anti-microbials are water-soluble salts of pyrithione, preferably sodium pyrithione (also known as sodium omadine or 2-pyridinethiol 1-oxide, sodium salt), or a watersoluble azide salt, preferably sodium azide.
- the hydrophobic component of the first layer is any suitable water-insoluble aromatic hydrocarbon or halogenated hydrocarbon or mixture thereof that sublimes continuously in air at ambient room temperatures ranging, for example, from about 50 to about 100 degrees F.
- a preferred hydrophobic component, for purposes of the invention is p-dichlorobenzene or naphthalene.
- the first layer can take any suitably permeable form which may be conventional.
- the first layer for example, can comprise shaped pellets of a homogeneous mixture of the hydrophobic and hydrophilic components or it can be laminated or formed with the hydrophilic component as small particulates spaced or distributed uniformly throughout a permeable matrix of the hydrophobic component.
- the adsorbent means is installed either in a conventional urinal with means for by-passing flushing water or in a urinal of the type where it is exposed to air and intermittent urine streams but not exposed to flushing water, as for example a portable toilet having an unflushed urinal with gravity feed through a flow line such as that described in the patent to Braxton, U.S. Pat. No. 4,285,077.
- the hydrophilic and hydrophobic components may contain a suitable deodorizing or sanitizing substance which may be conventional, or other excipient or a diluent.
- a suitable deodorizing or sanitizing substance which may be conventional, or other excipient or a diluent.
- the release of the water-soluble component is a discontinuous slow release coinciding with exposure to the intermittent urine streams occurring during the predetermined service life of the device.
- Such release of the antimicrobial, for purposes of the invention is important because as the adsorption in the second layer increases, the protein in the adsorbate requires to a corresponding extent of increasing inhibition of bacterial action that would otherwise result in bacterial degradation of the protein.
- the relative content and quantities of the hydrophilic and hydrophobic components in the first layer of the adsorbent means are subject to considerable variation depending on the operating conditions.
- the hydrophilic component is about 5 parts by weight of an antibacterial such as sodium azide or sodium omadine and the hydrophobic component is about 95 parts by weight of a sublimeable hydrocarbon such as para-dichlorobenzene or naphthalene
- sublimation and leaching from such a first layer weighing about 20 g. are satisfactory at room temperature over a service life of about 96 hours for an average total flow-through volume of about 80 liters.
- An unexpected feature is that release of the antibacterial is sufficient to inhibit bacterial growth and odor in the second layer of the conduit.
- the second urine-stream permeable layer in the conduit contains adsorbent material for urinary proteins which, for purposes of the invention, may be a conventional adsorbent.
- the adsorbent material for this purpose, can be any suitable solid phase material that serves to effectively adsorb the wanted urinary proteins from the fluid streams for a predetermined period or service life.
- the adsorbent suitably may be in the form of a bed of macroporous solids, pellets or equivalent form of suitable depth supported in the column or conduit by suitable means such as a screen, woven cloth or a base member having spaced openings or perforations allowing for support of the bed as well as gravity flow of fluid through the layers.
- the first and second layers preferably are spaced apart for purposes of maximizing exposure of the first layer to air sublimation.
- Preferred materials for adsorption are macroporous ion-exchange resins such as IRC-50 resin, of suitable mesh size such as 16-50 mesh.
- IRC-50 resin for example, adjusted by pretreatment to the acid side advantageously binds about 4% of the total proteins in whole human urine but 60% of the urokinase. Bound proteins are then eluted from the resin by increasing the ionic strength or the pH.
- less than about 250 g. of IRC-50 resin is sufficient for extraction of urokinase from up to 80 liters of whole urine.
- the resulting resin with adsorbate can be frozen for a period and then thawed at a later time as desired without appreciable loss of urokinase activity.
- the invention in another aspect relates a method of collecting urine proteins.
- the method comprises the steps of installing in a urinal the collection device as described above comprising a conduit and first and second urine-stream permeable layers in the conduit and subjecting the permeable layers of the conduit to contact with air and intermittent flow of gravity-fed urine streams under conditions affording leaching of the antimicrobial from the first layer into each of the urine streams and adsorption onto the second layer of urinary proteins from each of the resulting leachate streams.
- the resulting adsorbed urinary proteins are advantageously isolated as a recoverable solid phase adsorbate in the second layer, substantially free of odor and bacterial degradation of the adsorbed protein.
- FIG. 1 is a view in elevation, partly in section taken on line 1--1 of FIG. 2, of a preferred embodiment of a collection device with a removable funnel attachment, according to the invention
- FIG. 2 is a top view of the collection device of FIG. 1 with the funnel attachment removed;
- FIG. 3 is a side view, in section, of a urinal in which a collection device is installed.
- the adsorbent conduit 10 of FIG. 1 as shown has a cup-like cylindrical body 11 of suitable dimension (e.g., ca. 5 inch axial passage by ca. 6 inch diametral) that is open at the top edge 12 and partly open at the base 13 through spaced perforations 14 distributed uniformly over the base allowing for passage by gravity of urine streams downward into the open top through the conduit and outflow through the perforations 14 to a drain and waste reception means (not shown).
- the body 11 is provided at the top edge 12 with a funnel 15 having a shoulder 16 nesting removably within the top edge to facilitate collection and passage of urine streams into and through the adsorbent conduit.
- the top opening of the funnel 15 can be shaped to substantially cover the horizontal cross-section of the urinal but without touching the walls of the urinal, especially the back walls of the urinal, so that flushing water flows freely down the walls to the drain, substantially without touching the device, especially the funnel.
- flushing water (which is usually tap water) purposely, is not collected in the funnel.
- the base 13 is provided with feet 17a, 17b, 17c and 17d spaced apart so that the conduit can be placed in a urinal for collection purposes in a location over the urinal drain 18, FIG.
- the open top end of the conduit 10 presents a uniform flat surface of a first layer 20 comprising hydrophilic and hydrophobic components that cooperate, on exposure to air and intermittent urine streams as described above, to slowly release the leachable antimicrobial.
- the first layer 20 can take the form of a solid cake as shown, suitably perforated to make the layer permeable or it can take the form of one or more pellets or blocks supported on a screen and spaced above the second layer.
- a second layer 30 containing adsorbent for urinary proteins.
- the first layer is spaced axially above the second layer at a sufficient distance such that the first layer is kept exposed to air when not exposed to intermittent fluid stream or, in other words, fluid flow backup from the second layer to the first layer is avoided.
- the hydrophobic component of the first layer 20 sublimes continuously thereby gradually exposing the leachable antimicrobial of the hydrophilic component for slow release.
- the incremental quantity of leachable anti-microbial thus exposed is leached by the stream from the first layer 20 into the second layer 30.
- urinary proteins of the urine stream are adsorbed onto the adsorbent contained in the second layer thereby removing the proteins from the passing stream.
- the conduit device 10 serves to prevent flow of flushing water through the conduit.
- the adsorbent layer 30 is not exposed to large amounts of water containing undesirable ions such as calcium or zinc ions that if adsorbed would shorten the useful life of the adsorbent.
- the collection device 10 is made by loading the second layer 30 (onto a screen support) as a uniform bed of macroporous adsorbent such as ion-exchange resin IRC-50 (e.g., 350 grams) and then inserting on a support (not shown) the first layer 20 containing a homogeneous mixture of para-dichlorobenzene (95 parts by weight) and sodium amodine (5 parts by weight) in solid cake form (i.e., a solidified suspension of the sodium amodine in melted dichlorobenzine) made permeable to urine flow by perforating the cake uniformly for axial flow through the layer.
- the layers 20 and 30 can if desired be supported upon open mesh screens.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pathology (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (21)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/600,081 US4557863A (en) | 1984-04-13 | 1984-04-13 | Device for collection of proteins in a urinal and method of use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/600,081 US4557863A (en) | 1984-04-13 | 1984-04-13 | Device for collection of proteins in a urinal and method of use |
Publications (1)
Publication Number | Publication Date |
---|---|
US4557863A true US4557863A (en) | 1985-12-10 |
Family
ID=24402270
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US06/600,081 Expired - Lifetime US4557863A (en) | 1984-04-13 | 1984-04-13 | Device for collection of proteins in a urinal and method of use |
Country Status (1)
Country | Link |
---|---|
US (1) | US4557863A (en) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4604357A (en) * | 1984-04-13 | 1986-08-05 | Enzymes Of America | Antimicrobial disinfecting urinal block means and methods of use |
FR2742981A1 (en) * | 1995-12-29 | 1997-07-04 | Dan Saragosti | Apparatus to test biological fluid e.g. urine |
US6080711A (en) * | 1996-03-15 | 2000-06-27 | Amway Corporation | Powder detergent composition and method of making |
FR2885054A1 (en) * | 2005-04-29 | 2006-11-03 | Lassalle Jean Roland | Static electricity elimination device for e.g. water closet, has cover made up of conductive material for covering base and surrounding toilet or urinal, where cover is connected with rod connected with earth electrode by screw |
US20070266486A1 (en) * | 2006-05-22 | 2007-11-22 | Ed Ramirez | Urinal splash guard employing flexible bristles |
US9243394B2 (en) | 2011-09-20 | 2016-01-26 | Fresh Products, Inc. | Replaceable restroom urinal assemblies, including urinal screens |
USD778411S1 (en) | 2014-11-05 | 2017-02-07 | Fresh Products, Inc. | Urinal screen |
USD778412S1 (en) | 2014-11-10 | 2017-02-07 | Fresh Products, Inc. | Urinal screen |
US10087612B2 (en) | 2014-02-12 | 2018-10-02 | Fresh Products, Inc. | Floor shield |
US10145098B2 (en) | 2014-11-05 | 2018-12-04 | Fresh Products, Inc. | Urinal screens |
CN109692020A (en) * | 2018-12-28 | 2019-04-30 | 岑发兴 | A kind of Emergence urine examination equipment |
USD915786S1 (en) | 2018-08-31 | 2021-04-13 | Fresh Products, Inc. | Absorbent mat |
USD925009S1 (en) | 2018-10-25 | 2021-07-13 | Fresh Products, Inc. | Urinal screen |
US11585078B2 (en) | 2017-12-20 | 2023-02-21 | Fresh Products, Inc. | Urinal screens |
CN116098658A (en) * | 2023-03-13 | 2023-05-12 | 首都儿科研究所 | Drainage tube sample collection device |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3711377A (en) * | 1970-10-22 | 1973-01-16 | Barbara Sloane | Method of production of urokinase |
US3755083A (en) * | 1971-08-30 | 1973-08-28 | Rand Labor Inc | Method for recovering urokinase from urine containing the same |
US4306029A (en) * | 1980-04-30 | 1981-12-15 | Baxter Travenol Laboratories, Inc. | Urine storage containers with urease |
-
1984
- 1984-04-13 US US06/600,081 patent/US4557863A/en not_active Expired - Lifetime
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3711377A (en) * | 1970-10-22 | 1973-01-16 | Barbara Sloane | Method of production of urokinase |
US3755083A (en) * | 1971-08-30 | 1973-08-28 | Rand Labor Inc | Method for recovering urokinase from urine containing the same |
US4306029A (en) * | 1980-04-30 | 1981-12-15 | Baxter Travenol Laboratories, Inc. | Urine storage containers with urease |
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4604357A (en) * | 1984-04-13 | 1986-08-05 | Enzymes Of America | Antimicrobial disinfecting urinal block means and methods of use |
FR2742981A1 (en) * | 1995-12-29 | 1997-07-04 | Dan Saragosti | Apparatus to test biological fluid e.g. urine |
US6080711A (en) * | 1996-03-15 | 2000-06-27 | Amway Corporation | Powder detergent composition and method of making |
FR2885054A1 (en) * | 2005-04-29 | 2006-11-03 | Lassalle Jean Roland | Static electricity elimination device for e.g. water closet, has cover made up of conductive material for covering base and surrounding toilet or urinal, where cover is connected with rod connected with earth electrode by screw |
US20070266486A1 (en) * | 2006-05-22 | 2007-11-22 | Ed Ramirez | Urinal splash guard employing flexible bristles |
US8856977B2 (en) | 2006-05-22 | 2014-10-14 | Ed Ramirez | Urinal splash guard employing flexible bristles |
US9243394B2 (en) | 2011-09-20 | 2016-01-26 | Fresh Products, Inc. | Replaceable restroom urinal assemblies, including urinal screens |
US10087612B2 (en) | 2014-02-12 | 2018-10-02 | Fresh Products, Inc. | Floor shield |
US10145098B2 (en) | 2014-11-05 | 2018-12-04 | Fresh Products, Inc. | Urinal screens |
USD960329S1 (en) | 2014-11-05 | 2022-08-09 | The Fresh Products, Inc. | Urinal screen |
USD778411S1 (en) | 2014-11-05 | 2017-02-07 | Fresh Products, Inc. | Urinal screen |
US11781305B2 (en) | 2014-11-05 | 2023-10-10 | Fresh Products, Inc. | Urinal screens |
USD857181S1 (en) | 2014-11-05 | 2019-08-20 | Fresh Products, Inc. | Urinal screen |
US10501924B2 (en) | 2014-11-05 | 2019-12-10 | Fresh Products, Inc. | Urinal screens |
US11396745B2 (en) | 2014-11-05 | 2022-07-26 | Fresh Products, Inc. | Urinal screens |
US11198997B2 (en) | 2014-11-05 | 2021-12-14 | Fresh Products, Inc. | Urinal screens |
USD778412S1 (en) | 2014-11-10 | 2017-02-07 | Fresh Products, Inc. | Urinal screen |
US11585078B2 (en) | 2017-12-20 | 2023-02-21 | Fresh Products, Inc. | Urinal screens |
USD915786S1 (en) | 2018-08-31 | 2021-04-13 | Fresh Products, Inc. | Absorbent mat |
USD925009S1 (en) | 2018-10-25 | 2021-07-13 | Fresh Products, Inc. | Urinal screen |
CN109692020A (en) * | 2018-12-28 | 2019-04-30 | 岑发兴 | A kind of Emergence urine examination equipment |
CN116098658A (en) * | 2023-03-13 | 2023-05-12 | 首都儿科研究所 | Drainage tube sample collection device |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4557863A (en) | Device for collection of proteins in a urinal and method of use | |
Shekinah et al. | Adsorption of lead (II) from aqueous solution by activated carbon prepared from Eichhornia | |
US20060234994A1 (en) | Method and device for concentrating and stabilizing conjugated estrogens from mare urine | |
Banat et al. | Batch zinc removal from aqueous solution using dried animal bones | |
Udovic et al. | Fractionation and bioavailability of Cu in soil remediated by EDTA leaching and processed by earthworms (Lumbricus terrestris L.) | |
CH626467A5 (en) | ||
Lambert et al. | Adsorption of phosphate on iron-coated sand granules as a robust end-of-pipe purification strategy in the horticulture sector | |
US4604357A (en) | Antimicrobial disinfecting urinal block means and methods of use | |
US4285077A (en) | Apparatus for extracting proteins from urine | |
Parish et al. | Acute arsine poisoning in two workers cleaning a clogged drain | |
EP0380228A2 (en) | Water treatment | |
Tallkvist et al. | Nickel absorption from perfused rat jejunal and ileal segments | |
Peterson et al. | The excretion by sheep of" selenium incorporated into red clover (Trifolium pratense l.): the chemical nature of the excreted selenium and its uptake by three plant species | |
JPH06134474A (en) | Activated water tank for feeding livestock and poultry | |
JPH0151784B2 (en) | ||
Valderrama et al. | Adsorption of the emerging pollutants on Buena Vista landfill cover material and implications on regional aquatic pollution | |
JPH11183691A (en) | Method for treating liquid radioactive waste | |
EP1380333B1 (en) | Odour absorbing filters | |
CN108109713A (en) | A kind of processing method of radioactivity medical waste water | |
US1915874A (en) | Method of preventing the growth of alge | |
Bustos et al. | Adsorption considerations of dichlorvos in farm soils from the pampa plain (Argentina): Kinetics and equilibrium studies. | |
JPH10296272A (en) | Sterilizing agent for bath or the like | |
Jayampathi et al. | 1Department of Food Science & Technology, Faculty of Livestock, Fisheries and Nutrition, Wayamba University of Sri Lanka, Makandura, Sri Lanka, 2Ecosphere Resilience Research Center, Faculty of Applied Sciences, University of Sri Jayewardenepura, Nugegoda, Sri Lanka | |
JPH03159983A (en) | Agricultural material and production thereof | |
CZ304931B6 (en) | Method of removing platinum compounds and metabolites thereof from urine of patients treated by cytostatics and apparatus for making the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
CC | Certificate of correction | ||
FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
REMI | Maintenance fee reminder mailed | ||
FPAY | Fee payment |
Year of fee payment: 4 |
|
SULP | Surcharge for late payment | ||
AS | Assignment |
Owner name: PROTEIN COLLECTION TECHNOLOGIES, INC., A CORP. OF Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:BRAXTON, EARL J.;REEL/FRAME:005467/0765 Effective date: 19900925 |
|
AS | Assignment |
Owner name: ENZYMES OF AMERICA HOLDING CORP., MICHIGAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:PROTEIN COLLECTION TECHNOLOGIES, INC.;REEL/FRAME:006576/0478 Effective date: 19930429 |
|
FPAY | Fee payment |
Year of fee payment: 8 |
|
AS | Assignment |
Owner name: NATIONAL MANAGEMENT CORPORATION, MICHIGAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ENZYMES OF AMERICA HOLDING CORP.;REEL/FRAME:007118/0675 Effective date: 19940803 |
|
FEPP | Fee payment procedure |
Free format text: PAYER NUMBER DE-ASSIGNED (ORIGINAL EVENT CODE: RMPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
FPAY | Fee payment |
Year of fee payment: 12 |